Steven Cohen's TARA Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 1.15 M shares of Protara Therapeutics, Inc. (TARA) worth $6.01 M, representing 0.01% of the portfolio. First purchased in 2025-Q4, this recently established position has been held for 2 quarters.
Based on recent 13F filings, Steven Cohen has initiated a new position in TARA, representing a fresh investment thesis on this company. Largest addition occurred in Q1 2026, adding 1.12 M shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Protara Therapeutics (TARA) Holding Value Over Time
Track share changes against reported price movement
Quarterly Protara Therapeutics (TARA) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +1.12 M | Add 4001.16% | 1.15 M | $5.21 |
| Q4 2025 | +28,107 | New Buy | 28,107 | $5.33 |
Steven Cohen's Protara Therapeutics Investment FAQs
Steven Cohen first purchased Protara Therapeutics, Inc. (TARA) in Q4 2025, acquiring 28,107 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Protara Therapeutics, Inc. (TARA) for 2 quarters since Q4 2025.
Steven Cohen's largest addition to Protara Therapeutics, Inc. (TARA) was in Q1 2026, adding 1,152,714 shares worth $6.01 M.
According to the latest 13F filing for Q1 2026, Steven Cohen's firm, Point72 Asset Management, L.P., owns 1,152,714 shares of Protara Therapeutics, Inc. (TARA), valued at approximately $6.01 M.
As of the Q1 2026 filing, Protara Therapeutics, Inc. (TARA) represents approximately 0.01% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Protara Therapeutics, Inc. (TARA) was 1,152,714 shares, as reported at the end of Q1 2026.